ScholarIQanswers from OpenAlex
Helsinn Therapeutics
FunderResearch funding and supported work
Helsinn Therapeutics is a funder indexed in ScholarIQ from OpenAlex.
What is known about Helsinn Therapeutics?
ScholarIQrecord summary
company in Iselin, United States
How many works does Helsinn Therapeutics have?
ScholarIQindexed works
Helsinn Therapeutics has 132 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Helsinn Therapeutics?
ScholarIQopenalex
The OpenAlex for Helsinn Therapeutics is on the source record.
What is the ROR of Helsinn Therapeutics?
ScholarIQror
The ROR for Helsinn Therapeutics is on the source record.
What are the most-cited papers on Helsinn Therapeutics?
ScholarIQmost cited works
Concurrent RB1 and TP53 Alterations Define a Subset of EGFR-Mutant Lung Cancers at risk for Histologic Transformation and Inferior Clinical Outcomes
Michael Offin, Joseph M. Chan, Megan Tenet, Hira Rizvi, Ronglai Shen, Gregory J. Riely, Natasha Rekhtman, Yahya Daneshbod, Àlvaro Quintanal-Villalonga, Alexander Penson, Matthew D. Hellmann, Maria E. Arcila, Marc Ladanyi, Dana Pe’er, Mark G. Kris, Charles M. Rudin, Helena A. Yu